Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (TSE:AGN)
:AGN
AGN Stock Chart & Stats
C$0.08
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.08
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.12
Previous CloseN/A
Volume3.18K
Average Volume (3M)13.80K
Market Cap
C$2.57M
Enterprise ValueC$2.24M
Total Cash (Recent Filing)C$88.18K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.50
Next Earnings
Dec 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding34,256,218
10 Day Avg. Volume14,017
30 Day Avg. Volume13,803
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.97
Price to Sales (P/S)0.00
P/FCF Ratio-0.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Algernon Pharmaceuticals News
AGN FAQ
What was Algernon Pharmaceuticals’s price range in the past 12 months?
Algernon Pharmaceuticals lowest stock price was C$0.06 and its highest was C$0.12 in the past 12 months.
What is Algernon Pharmaceuticals’s market cap?
Algernon Pharmaceuticals’s market cap is C$2.57M.
When is Algernon Pharmaceuticals’s upcoming earnings report date?
Algernon Pharmaceuticals’s upcoming earnings report date is Dec 22, 2025 which is in 25 days.
How were Algernon Pharmaceuticals’s earnings last quarter?
Algernon Pharmaceuticals released its earnings results on Jul 30, 2025. The company reported -C$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.02.
Is Algernon Pharmaceuticals overvalued?
According to Wall Street analysts Algernon Pharmaceuticals’s price is currently Overvalued.
Does Algernon Pharmaceuticals pay dividends?
Algernon Pharmaceuticals does not currently pay dividends.
What is Algernon Pharmaceuticals’s EPS estimate?
Algernon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Algernon Pharmaceuticals have?
Algernon Pharmaceuticals has 34,256,218 shares outstanding.
What happened to Algernon Pharmaceuticals’s price movement after its last earnings report?
Algernon Pharmaceuticals reported an EPS of -C$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Algernon Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:AGN
Company Description
Algernon Pharmaceuticals
Algernon Pharmaceuticals (AGN) is a clinical stage pharmaceutical development company focused on the discovery and development of novel therapeutic compounds for the treatment of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD), acute and chronic cough, and fibrotic diseases. The company's innovative approach involves investigating and repurposing existing drugs to potentially expedite the development process and bring treatments to market more efficiently.
Technical Analysis
Options Prices
Currently, No data available
---